000 01593 a2200421 4500
005 20250517132403.0
264 0 _c20170906
008 201709s 0 0 eng d
022 _a1473-4877
024 7 _a10.1080/03007995.2016.1277195
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHuffstutter, Joseph E
245 0 0 _aClinical response to golimumab in rheumatoid arthritis patients who were receiving etanercept or adalimumab: results of a multicenter active treatment study.
_h[electronic resource]
260 _bCurrent medical research and opinion
_c04 2017
300 _a657-666 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
650 0 4 _aAdalimumab
_xadministration & dosage
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntibodies, Monoclonal
_xadministration & dosage
650 0 4 _aAntirheumatic Agents
_xadministration & dosage
650 0 4 _aArthritis, Rheumatoid
_xdrug therapy
650 0 4 _aDrug Therapy, Combination
650 0 4 _aEtanercept
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
700 1 _aKafka, Shelly
700 1 _aBrent, Lawrence H
700 1 _aMatucci-Cerinic, Marco
700 1 _aTang, Kezhen L
700 1 _aChevrier, Marc
700 1 _aSprabery, Trev
700 1 _aDeHoratius, Raphael J
773 0 _tCurrent medical research and opinion
_gvol. 33
_gno. 4
_gp. 657-666
856 4 0 _uhttps://doi.org/10.1080/03007995.2016.1277195
_zAvailable from publisher's website
999 _c26742261
_d26742261